GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DocMorris AG (OTCPK:ZRSEF) » Definitions » Beneish M-Score

DocMorris AG (DocMorris AG) Beneish M-Score : -2.02 (As of Jun. 24, 2024)


View and export this data going back to 2018. Start your Free Trial

What is DocMorris AG Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.02 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for DocMorris AG's Beneish M-Score or its related term are showing as below:

ZRSEF' s Beneish M-Score Range Over the Past 10 Years
Min: -2.82   Med: -2.38   Max: -2.02
Current: -2.02

During the past 13 years, the highest Beneish M-Score of DocMorris AG was -2.02. The lowest was -2.82. And the median was -2.38.


DocMorris AG Beneish M-Score Historical Data

The historical data trend for DocMorris AG's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DocMorris AG Beneish M-Score Chart

DocMorris AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.31 -2.79 -2.76 -2.35 -2.02

DocMorris AG Semi-Annual Data
Dec12 Dec13 Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.76 - -2.35 - -2.02

Competitive Comparison of DocMorris AG's Beneish M-Score

For the Pharmaceutical Retailers subindustry, DocMorris AG's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DocMorris AG's Beneish M-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DocMorris AG's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where DocMorris AG's Beneish M-Score falls into.



DocMorris AG Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of DocMorris AG for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.4478+0.528 * 0.8201+0.404 * 1.0681+0.892 * 1.1218+0.115 * 0.7056
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.8411+4.679 * 0.195856-0.327 * 0.7197
=-1.95

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was $80 Mil.
Revenue was $1,121 Mil.
Gross Profit was $235 Mil.
Total Current Assets was $340 Mil.
Total Assets was $1,002 Mil.
Property, Plant and Equipment(Net PPE) was $72 Mil.
Depreciation, Depletion and Amortization(DDA) was $50 Mil.
Selling, General, & Admin. Expense(SGA) was $141 Mil.
Total Current Liabilities was $209 Mil.
Long-Term Debt & Capital Lease Obligation was $273 Mil.
Net Income was $95 Mil.
Gross Profit was $0 Mil.
Cash Flow from Operations was $-101 Mil.
Total Receivables was $159 Mil.
Revenue was $999 Mil.
Gross Profit was $172 Mil.
Total Current Assets was $425 Mil.
Total Assets was $1,180 Mil.
Property, Plant and Equipment(Net PPE) was $104 Mil.
Depreciation, Depletion and Amortization(DDA) was $43 Mil.
Selling, General, & Admin. Expense(SGA) was $150 Mil.
Total Current Liabilities was $259 Mil.
Long-Term Debt & Capital Lease Obligation was $529 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(79.72 / 1121.025) / (158.697 / 999.323)
=0.071113 / 0.158805
=0.4478

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(171.91 / 999.323) / (235.139 / 1121.025)
=0.172026 / 0.209754
=0.8201

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (339.586 + 71.755) / 1001.877) / (1 - (424.951 + 103.916) / 1180.169)
=0.58943 / 0.551872
=1.0681

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=1121.025 / 999.323
=1.1218

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(42.552 / (42.552 + 103.916)) / (50.227 / (50.227 + 71.755))
=0.290521 / 0.411757
=0.7056

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(141.189 / 1121.025) / (149.633 / 999.323)
=0.125946 / 0.149734
=0.8411

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((273.21 + 208.509) / 1001.877) / ((529.336 + 259.069) / 1180.169)
=0.480817 / 0.668044
=0.7197

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(95.143 - 0 - -101.081) / 1001.877
=0.195856

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

DocMorris AG has a M-score of -1.95 suggests that the company is unlikely to be a manipulator.


DocMorris AG Beneish M-Score Related Terms

Thank you for viewing the detailed overview of DocMorris AG's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


DocMorris AG (DocMorris AG) Business Description

Traded in Other Exchanges
Address
Walzmuhlestrasse 60, Frauenfeld, CHE, 8500
DocMorris AG is an online pharmacy company and wholesale supplier to medical practitioners in Switzerland. The Group's reportable segments are Switzerland, Germany, and Europe. The operating segment in Switzerland comprises the wholesale business of supplying medical products to Swiss medical practitioners and the retail business that is focused on providing end consumers with drugs and health products from Zur Rose. The Germany segment comprises the mail-order business in drugs and health products, as well as services for mail-order pharmacies. The operating segment Europe comprises the marketplace business of PromoFarma and Doctipharma. Majority of revenue is generated from Germany segment.

DocMorris AG (DocMorris AG) Headlines

From GuruFocus

Zur Rose Group AG Capital Markets Day (Virtual) Transcript

By GuruFocus Research 02-15-2024

Full Year 2022 Zur Rose Group AG Earnings Call Transcript

By GuruFocus Research 02-15-2024

Half Year 2021 Zur Rose Group AG Earnings Call Transcript

By GuruFocus Research 02-15-2024

Half Year 2020 Zur Rose Group AG Earnings Call Transcript

By GuruFocus Research 02-15-2024

Half Year 2023 Zur Rose Group AG Earnings Call Transcript

By GuruFocus Research 02-15-2024

Full Year 2019 Zur Rose Group AG Earnings Call Transcript

By GuruFocus Research 02-15-2024

Full Year 2021 Zur Rose Group AG Earnings Call Transcript

By GuruFocus Research 02-15-2024

Full Year 2020 Zur Rose Group AG Earnings Call Transcript

By GuruFocus Research 02-15-2024

Half Year 2022 Zur Rose Group AG Earnings Call Transcript

By GuruFocus Research 02-15-2024